Back to Stories & News

DENVER/November 15, 2021 – Morris Animal Foundation is now accepting research proposals for access to data and/or biological samples collected as part of its Golden Retriever Lifetime Study.

Successful proposals will contribute to the understanding of nutritional, environmental, lifestyle and genetic risk factors for cancer and other diseases in dogs with the goal of generating data to identify priorities for further study. Grant applications are due by 11:59 p.m. MT, January 14, 2022. Please note this call does not include funding.

Interested researchers must first fill out a Proposal Request Form, providing an overview of their proposal. Applicants will be contacted to discuss next steps within two to three weeks.

The Foundation’s Golden Retriever Lifetime Study is a groundbreaking, longitudinal study begun in 2012 with an enrolled cohort of 3,044 dogs. The dataset is comprised of owner and veterinarian reports via annual questionnaires. Available biological samples include whole blood, DNA, urine, hair and toenails, collected annually from the cohort of privately owned dogs living throughout the lower 48 United States.

The primary goal of the Golden Retriever Lifetime Study is to identify the incidence of and risk factors for osteosarcoma, hemangiosarcoma, lymphoma and high-grade mast cell tumors. Histiocytic sarcoma has emerged as a cancer of interest and is being closely tracked as well. Secondary goals include understanding other disease processes common in golden retrievers and dogs in general, including conditions such as hypothyroidism, atopy, orthopedic problems and heart disease.

Visit the Morris Animal Foundation Golden Retriever Lifetime Study RFP page to begin the application process. For questions, contact [email protected].

About Morris Animal Foundation

Morris Animal Foundation’s mission is to bridge science and resources to advance the health of animals. Founded in 1948 and headquartered in Denver, it is one of the largest nonprofit animal health research organizations in the world, funding more than $142 million in critical health studies across a broad range of species. Learn more at